Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
SBB Gains EUR 16 Million One-Off Tax Refund in Finland

SBB Gains EUR 16 Million One-Off Tax Refund in Finland

BitgetBitget2026/11/06 11:46
  • SBB will receive a Finnish tax refund of EUR 16 million, equivalent to approximately SEK 177 million at today's exchange rate.
  • The one-off refund will reduce tax expense in the fourth quarter of 2026, boosting earnings by the refunded amount.
  • A favorable reassessment concludes a two-year process covering previously paid current tax.
  • Interest is excluded from the refund amount, with total cash inflow expected to be slightly higher, strengthening liquidity.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samhallsbyggnadsbolaget I Norden AB published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12